Cell & Gene Therapy - Case Western Researchers Use Stem Cells to “Shut Off” Nerve Cell Strain
View as a Web Page
News Medical
 
  Cell & Gene Therapy Cell & Gene Therapy logo  
  The latest stem cells news from News Medical  
 

Introducing SAFENSURE™ – Your Biologics Safety Testing Solution!Introducing SAFENSURE™ – Your Biologics Safety Testing Solution!

SAFENSURE™ is a specialized brand developed by ACROBiosystems, offering comprehensive safety testing solutions for biologics. Aligned with global pharmacopeias and biopharma regulations, SAFENSURE™ offers validated assay kits to ensure regulatory compliance and product safety.
Their advanced Recombinant Factor C Endotoxin Detection kit delivers high sensitivity, accurate, and animal-free alternative to traditional methods.

Explore SAFENSURE™ today
 
   Case Western Researchers Use Stem Cells to “Shut Off” Nerve Cell StrainCase Western Researchers Use Stem Cells to “Shut Off” Nerve Cell Strain
 
Amyotrophic lateral sclerosis (ALS), sometimes known as Lou Gehrig’s disease, is an incurable neurological disease that affects motor neurons, which are nerve cells in the brain and spinal cord that regulate voluntary muscle movement and breathing.
 
   CRISPR and the Ethics of Human Germline InterventionCRISPR and the Ethics of Human Germline Intervention
 
The use of CRISPR-Cas9 in germline editing presents opportunities for genetic disease correction, alongside risks of off-target effects and ethical issues.
 
 Gene editing in the brain offers hope for ultra-rare neurological disease
 
Gene editing in the brain offers hope for ultra-rare neurological diseaseScientists have corrected gene mutations in mice causing an ultra-rare disease by editing DNA directly in the brain with a single injection, a feat with profound implications for patients with neurological diseases.
 
 
 New cellular entry pathway improves gene therapy outcomes
 
New cellular entry pathway improves gene therapy outcomesScientists from the Centenary Institute and the University of Sydney have made a landmark discovery that could lead to safer and more effective gene therapies for a range of serious genetic disorders including Duchenne muscular dystrophy, Pompe disease and hemophilia.
 
 
 UC Davis researchers pioneer safer gene therapy for vision loss
 
UC Davis researchers pioneer safer gene therapy for vision lossThe UC Davis Department of Ophthalmology has received a five-year, $3.6 million grant from the National Eye Institute to explore a new way to treat vision loss using gene therapy.
 
 
 New approach makes mismatched stem cell transplants safer for blood cancer patients
 
New approach makes mismatched stem cell transplants safer for blood cancer patientsAdvances in blood stem cell transplants now make it possible for people with blood cancers to get safe and effective "mismatched" transplants that will potentially cure their disease, new UVA Cancer Center research reveals. The advances will allow far more people to receive the lifesaving treatment.
 
 
 Single injection of gene therapy at birth may offer lasting protection against HIV
 
Single injection of gene therapy at birth may offer lasting protection against HIVA new study in Nature shows that delivering a single injection of gene therapy at birth may offer years-long protection against HIV, tapping into a critical window in early life that could reshape the fight against pediatric infections in high-risk regions.
 
 
 Researchers create over 400 types of nerve cells from stem cells
 
Researchers create over 400 types of nerve cells from stem cellsNerve cells are not just nerve cells. Depending on how finely we distinguish, there are several hundred to several thousand different types of nerve cell in the human brain according to the latest calculations.
 
 

How would you rate today's newsletter?

 
             
 
 
Google News Icon Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025